Floatz logo

Telmisartan

Abdominal Obesity-Metabolic Syndrome

Hamdard UniversitySmall moleculePhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
73/ 100

Competitive context

41 Active assets in the Abdominal Obesity-Metabolic Syndrome cohort.

Asset / SponsorPhaseRating
Topiramate
All India Institute of Medical Sciences, Bhubaneswar
Phase 4BBB
ATORVASTATIN
Seoul National University Hospital
Phase 4BBB
Pioglitazone
Philip Kern
Phase 4BBB
SIMVASTATIN
Jaime Daniel Mondragon
Phase 4BBB
OLMESARTAN MEDOXOMIL
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Phase 4BBB

View all 50 →

Same molecule, other indications

Telmisartan is also rated in:

hypertensive disorderDormant
BB
Indicative · Phase 4
71 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative · Phase 4
68 / 100
View asset →
essential hypertensionActive
B
Indicative · Phase 4
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →